作者
Alistair BA Boxall, Murray A Rudd, Bryan W Brooks, Daniel J Caldwell, Kyungho Choi, Silke Hickmann, Elizabeth Innes, Kim Ostapyk, Jane P Staveley, Tim Verslycke, Gerald T Ankley, Karen F Beazley, Scott E Belanger, Jason P Berninger, Pedro Carriquiriborde, Anja Coors, Paul C DeLeo, Scott D Dyer, Jon F Ericson, François Gagné, John P Giesy, Todd Gouin, Lars Hallstrom, Maja V Karlsson, DG Joakim Larsson, James M Lazorchak, Frank Mastrocco, Alison McLaughlin, Mark E McMaster, Roger D Meyerhoff, Roberta Moore, Joanne L Parrott, Jason R Snape, Richard Murray-Smith, Mark R Servos, Paul K Sibley, Jürg Oliver Straub, Nora D Szabo, Edward Topp, Gerald R Tetreault, Vance L Trudeau, Glen Van Der Kraak
发表日期
2012/9
来源
Environmental health perspectives
卷号
120
期号
9
页码范围
1221-1229
出版商
National Institute of Environmental Health Sciences
简介
Background: Over the past 10–15 years, a substantial amount of work has been done by the scientific, regulatory, and business communities to elucidate the effects and risks of pharmaceuticals and personal care products (PPCPs) in the environment.
Objective: This review was undertaken to identify key outstanding issues regarding the effects of PPCPs on human and ecological health in order to ensure that future resources will be focused on the most important areas.
Data sources: To better understand and manage the risks of PPCPs in the environment, we used the “key question” approach to identify the principle issues that need to be addressed. Initially, questions were solicited from academic, government, and business communities around the world. A list of 101 questions was then discussed at an international expert workshop, and a top-20 list was developed. Following the workshop, workshop attendees …
引用总数
学术搜索中的文章
ABA Boxall, MA Rudd, BW Brooks, DJ Caldwell, K Choi… - Environmental health perspectives, 2012